Search Results - "Falci, Diego"

Refine Results
  1. 1
  2. 2

    Neglected endemic mycoses by Queiroz-Telles, Flavio, Fahal, Ahmed Hassan, Falci, Diego R, Caceres, Diego H, Chiller, Tom, Pasqualotto, Alessandro C

    Published in The Lancet infectious diseases (01-11-2017)
    “…Fungi often infect mammalian hosts via the respiratory route, but traumatic transcutaneous implantation is also an important source of infections…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities by Falci, Diego R., Pasqualotto, Alessandro C.

    Published in Mycoses (01-04-2019)
    “…Summary Despite the existence of endemic mycoses in Latin America and the Caribbean, in addition to a large population of patients at risk for invasive…”
    Get full text
    Journal Article
  6. 6

    Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity by Nation, Roger L, Rigatto, Maria Helena P, Falci, Diego R, Zavascki, Alexandre P

    Published in Antibiotics (Basel) (14-03-2019)
    “…Polymyxins are valuable antimicrobials for the management of multidrug-resistant Gram-negative bacteria; however, nephrotoxicity associated with these drugs is…”
    Get full text
    Journal Article
  7. 7

    Clinical Characteristics of Covid-19 in China by Zavascki, Alexandre P, Falci, Diego R, Chen, Andre T.C, Coura-Filho, George B, Rehder, Marília H.H, Rolf, J. Douglass, Henry, Brandon M, Vikse, Jens, Guan, Wei-jie, Zhong, Nan-shan

    Published in The New England journal of medicine (07-05-2020)
    “…To the Editor: According to the World Health Organization (WHO), the case definition for surveillance of returning travelers requires that they need to present…”
    Get full text
    Journal Article
  8. 8

    Single-Dose Amphotericin B for Cryptococcal Meningitis by Falci, Diego R., Pasqualotto, Alessandro C., Lawrence, David S., Harrison, Thomas S., Jarvis, Joseph N.

    Published in The New England journal of medicine (28-07-2022)
    “…To the Editor: Jarvis et al. (March 24 issue) 1 showed that a regimen that included a single dose of liposomal amphotericin B (10 mg per kilogram of body…”
    Get full text
    Journal Article
  9. 9

    Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B by John, Josiane F, Falci, Diego R, Rigatto, Maria Helena, Oliveira, Renata D, Kremer, Thaysa G, Zavascki, Alexandre P

    Published in Antimicrobial agents and chemotherapy (01-01-2018)
    “…The use of very high doses of polymyxin B (PMB) against carbapenem-resistant Gram-negative bacilli has been addressed in experiments as a strategy to improve…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections by Falci, Diego R, Pasqualotto, Alessandro C

    Published in Infection and drug resistance (22-10-2013)
    “…The triazole class of antifungal drugs comprises first-line agents for the treatment of several invasive fungal diseases. Isavuconazole is a novel…”
    Get full text
    Journal Article
  12. 12

    Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: A systematic review and meta-analysis by Cipolat, Murillo M, Rodrigues, Débora R R, Brenol, Claiton V, Pasqualotto, Alessandro C, Falci, Diego R

    Published in Medicine (Baltimore) (08-12-2023)
    “…Immunobiological drugs such as TNF-α inhibitors are valuable in rescue therapy for autoimmune diseases such as rheumatoid arthritis and inflammatory bowel…”
    Get full text
    Journal Article
  13. 13

    Early antiretroviral therapy for HIV-infected patients admitted to an intensive care unit (EARTH-ICU): A randomized clinical trial by Boniatti, Márcio M, Pellegrini, José Augusto S, Marques, Leonardo S, John, Josiane F, Marin, Luiz G, Maito, Lina R. D. M, Lisboa, Thiago C, Damiani, Lucas P, Falci, Diego R, Dal Pizzol, Felipe

    Published in PloS one (21-09-2020)
    “…Background Highly active antiretroviral therapy (HAART) has reduced HIV-related morbidity and mortality at all stages of infection and reduced transmission of…”
    Get full text
    Journal Article
  14. 14

    Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study by Rigatto, Maria Helena, Behle, Tainá F, Falci, Diego R, Freitas, Thiela, Lopes, Natane T, Nunes, Mariá, Costa, Leonardo W, Zavascki, Alexandre P

    Published in Journal of antimicrobial chemotherapy (01-05-2015)
    “…The objectives of this study were to assess risk factors for acute kidney injury (AKI) in patients treated with polymyxin B, a last resort antibiotic against…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Impact of polymyxin-B-associated acute kidney injury in 1-year mortality and renal function recovery by Gomes, Eduardo C., Falci, Diego R., Bergo, Pedro, Zavascki, Alexandre P., Rigatto, Maria Helena

    “…•46.1% of patients who survived the first 30 days after PMB died within 1 year.•Renal failure and dialyses during PMB therapy were related to 1-year…”
    Get full text
    Journal Article
  18. 18

    Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study by Falci, Diego R., da Rosa, Franciane B., Pasqualotto, Alessandro C.

    Published in Mycoses (01-02-2015)
    “…Summary Amphotericin B (AmB) use is limited by the occurrence of kidney toxicity. Here, we evaluated the incidence and impact of nephrotoxicity in a large…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Hematological toxicities associated with amphotericin B formulations by Falci, Diego R, da Rosa, Franciane B, Pasqualotto, Alessandro C

    Published in Leukemia & lymphoma (03-10-2015)
    “…Even though amphotericin B is associated with considerable hematological toxicity, this subject has been poorly studied. This retrospective cohort study…”
    Get full text
    Journal Article